William E. Martin, III

William E. Martin, III

Former Chief Executive OfficeratMaravai Lifesciences Holdings· In proxies 2022–2025

Pay in FY2025-40% from the year before · Maravai Lifesciences Holdings stock -40.4% the same year

William E. Martin, III was paid $3.8M in FY2025 (Dec), down 40%. Maravai Lifesciences Holdings stock fell 40.4% that year.

Pay$100 in the stock at the end of FY21 → $8
Pay is from the Summary Compensation Table of each Maravai Lifesciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Maravai Lifesciences HoldingsPublic company · 4 yr
    • Former Chief Executive Officer2022 – Present · 4 yrStock in role -80%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?